Table 5.

TXA in Body Contouring

Authors	Journal and Year	Study Design	Study Group (Total No.)	Surgery Type	Administration Mode, Time, and Dosage	Main Clinical Outcome	Main Results	Complications Related to TXA
Cansancao et al	Plastic & Reconstructive Surgery Journal 2018	NRCT	10 (20)No significant difference between the 2 groups	Liposuction	IV: 10 mg/kg of TXA 30 min preoperatively and postoperatively	Blood volume of the total lipoaspirateHematocrit level	37% less perioperative blood loss (P < 0.05)56.2% less blood loss for every liter of supernatant (P < 0.001)48% less drop in hematocrit levels at POD 7 (P = 0.001)	None

N/A, not available; NRCT, nonrandomized controlled trial.